Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

Cameron, DA, Anderson, A, Toy, E et al. (9 more authors) (2002) Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? British Journal of Cancer, 87 (12). pp. 1365-1369. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2002 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: anthracycline; adjuvant; breast cancer; survival
Dates:
  • Published: 26 November 2002
  • Accepted: 23 September 2002
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds) > National Institute for Health Research (Leeds) > NCRN (NIHR Cancer Research Network) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > Medicine & Health Faculty Office (Leeds) > National Institute for Health Research (Leeds) > NCRN (NIHR Cancer Research Network) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Medicine & Health Faculty Office (Leeds) > National Institute for Health Research (Leeds) > NCRN (NIHR Cancer Research Network) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Jul 2016 11:19
Last Modified: 14 Jul 2016 11:19
Published Version: http://dx.doi.org/10.1038/sj.bjc.6600660
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/sj.bjc.6600660

Share / Export

Statistics